• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    First Wave Biopharma Inc (NQ: FWBI )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, May 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about First Wave Biopharma Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      During Tuesday's trading, 46 companies set new 52-week lows. 
    Via Benzinga
    Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
    Via Benzinga
    Expert Ratings for First Wave BioPharma
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
    Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning. 
    Via InvestorPlace
    What 4 Analyst Ratings Have To Say About First Wave BioPharma
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Expert Ratings for First Wave BioPharma
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
    Via Benzinga
    Crude Oil Rises 1.5%; PepsiCo Earnings Top Views
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Thursday. The Dow traded up 0.15% to 34,397.80 while the NASDAQ rose 1.40% to 14,114.17. The S&P 500,... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers 
    Via Benzinga
    Nasdaq Rises Over 100 Points; Delta Air Lines Posts Upbeat Results
    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. The Dow traded up 0.13% to 34,392.36 while the NASDAQ rose 0.97% to 14,054.23. The S&P... 
    Via Benzinga
    Dow Gains Over 100 Points; US Producer Prices Rise 0.1% In June
    U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.31% to 34,454.88 while the NASDAQ rose 0.98%... 
    Via Benzinga
    Why Are First Wave BioPharma Shares Tanking Today
    First Wave BioPharma Inc (NASDAQ: FWBI) shares are trading lower after the company received topline results from its Phase 2 SPAN trial investigating an enhanced enteric microgranule delivery... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Nasdaq Gains Over 50 Points; First Wave BioPharma Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.23% to 34,144.24 while the NASDAQ rose 0.42% to 13,518.40. The S&P 500,... 
    Via Benzinga
    First Wave BioPharma (NASDAQ: FWBI) Makes Significant Progress in Phase 2 SPAN Clinical Trial
    Trial Enrollment Completed for Investigational Therapy of Exocrine Pancreatic Insufficiency First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company 
    Via Spotlight Growth
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic... 
    Via Benzinga
    Crude Oil Rises Sharply; Auddia Shares Plummet
    U.S. stocks traded higher midway through trading, with Dow Jones gaining over 100 points on Tuesday. The Dow traded up 0.42% to 34,210.67 while the NASDAQ rose 0.43% to 13,519.68. The S&P 500, also... 
    Via Benzinga
    Why First Wave BioPharma Stock Has More Than Doubled Today
    First Wave BioPharma Inc (NASDAQ: FWBI) shares are trading higher after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic insufficiency  
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 29 companies set new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 63 companies hit new 52-week lows. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.